Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date Vladimir LernerPeter J. A. McCafferyMichael S. Ritsner Leading Article 11 March 2016 Pages: 269 - 280
A Review of Pharmacologic Treatment for Compulsive Buying Disorder Célia SoaresNatália FernandesPedro Morgado Review Article 11 April 2016 Pages: 281 - 291
Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management Jan JaraczKarolina GattnerKrystyna Górna Review Article Open access 05 April 2016 Pages: 293 - 304
The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome Alon Y. AvidanDaniel LeeRichard Kim Original Research Article 11 April 2016 Pages: 305 - 316
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database Chris BusheEsther SobanskiSami Leppämäki Original Research Article 07 April 2016 Pages: 317 - 334
Brexpiprazole: A Review in Schizophrenia Karly P. Garnock-Jones Adis Drug Evaluation 29 March 2016 Pages: 335 - 342
Lisdexamfetamine: A Review in ADHD in Adults James E. Frampton Adis Drug Evaluation 05 April 2016 Pages: 343 - 354
Erratum to: Targeting CGRP: A New Era for Migraine Treatment Stephanie Wrobel GoldbergStephen David Silberstein Erratum 11 April 2016 Pages: 355 - 355